FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293766356> ?p ?o ?g. }

• W4293766356 endingPage "1950" @default.
• W4293766356 startingPage "1939" @default.
• W4293766356 abstract "Major depressive disorder (MDD) affects >163 million people worldwide and is a leading cause of disability in China. Functional impairment occurs alongside cognitive symptoms, anxiety, and depression, reducing quality of life and productivity in patients with MDD.The multimodal antidepressant vortioxetine has demonstrated efficacy in relieving depressive and functional symptoms of MDD in randomized controlled trials (RCTs). The RELIEVE China study aimed to investigate the real-world effectiveness of vortioxetine in China.This was an observational, prospective cohort study in patients with MDD initiating treatment with vortioxetine at physician's discretion in China. Participants were followed up for 24 weeks and assessed at 3 time points: baseline, week 8, and week 24. The primary objective was to assess the change from baseline to weeks 8 and 24 in functional impairment as measured by Sheehan Disability Scale (SDS) total score. Additional assessments included SDS subdomains, measures of depression severity, anxiety, and cognition. The safety and tolerability of vortioxetine were also examined.In total, 859 patients were included in the analysis. A consistent and significant improvement in functional impairment was observed during the study, with baseline mean SDS total score (16.7 points) decreasing by 5.42 (SE, 0.22) and 8.71 (SE, 0.226) points at week 8 and week 24, respectively (P<0.0001). Improvements in other functioning, cognitive, and anxiety assessments were also observed (all P<0.0001). A total of 74.7% of patients had responded, and 63.9% had reached remission at week 24. The tolerability profile of vortioxetine in this real-world population was consistent with the established tolerability profile for this drug.This study demonstrated the short- and long-term effectiveness and tolerability of vortioxetine for patients with MDD in a real-world setting in China. These findings are consistent with the efficacy and safety profile observed during RCTs." @default.
• W4293766356 created "2022-08-31" @default.
• W4293766356 creator A5012816071 @default.
• W4293766356 creator A5024700132 @default.
• W4293766356 creator A5030921116 @default.
• W4293766356 creator A5033516838 @default.
• W4293766356 creator A5035472496 @default.
• W4293766356 creator A5041837471 @default.
• W4293766356 creator A5049218383 @default.
• W4293766356 creator A5058901425 @default.
• W4293766356 creator A5063464747 @default.
• W4293766356 creator A5068851817 @default.
• W4293766356 creator A5077989094 @default.
• W4293766356 date "2022-08-01" @default.
• W4293766356 modified "2023-10-03" @default.
• W4293766356 title "Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study" @default.
• W4293766356 cites W1781131011 @default.
• W4293766356 cites W1967366594 @default.
• W4293766356 cites W1971568036 @default.
• W4293766356 cites W1986101205 @default.
• W4293766356 cites W2005573272 @default.
• W4293766356 cites W2005792051 @default.
• W4293766356 cites W2011606125 @default.
• W4293766356 cites W2030794561 @default.
• W4293766356 cites W2084647249 @default.
• W4293766356 cites W2114371710 @default.
• W4293766356 cites W2120729896 @default.
• W4293766356 cites W2153644230 @default.
• W4293766356 cites W2270496518 @default.
• W4293766356 cites W2303297560 @default.
• W4293766356 cites W2403465849 @default.
• W4293766356 cites W2436735416 @default.
• W4293766356 cites W2560719772 @default.
• W4293766356 cites W2585266158 @default.
• W4293766356 cites W2912654919 @default.
• W4293766356 cites W2916226351 @default.
• W4293766356 cites W2954944633 @default.
• W4293766356 cites W2984968108 @default.
• W4293766356 cites W2990123963 @default.
• W4293766356 cites W3009211512 @default.
• W4293766356 cites W3011400372 @default.
• W4293766356 cites W3032568933 @default.
• W4293766356 cites W3088257423 @default.
• W4293766356 cites W3111518135 @default.
• W4293766356 cites W3111789454 @default.
• W4293766356 cites W3128264823 @default.
• W4293766356 cites W3167116376 @default.
• W4293766356 cites W3168254863 @default.
• W4293766356 cites W3201200719 @default.
• W4293766356 cites W4200232405 @default.
• W4293766356 doi "https://doi.org/10.2147/ndt.s358253" @default.
• W4293766356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36065389" @default.
• W4293766356 hasPublicationYear "2022" @default.
• W4293766356 type Work @default.
• W4293766356 citedByCount "5" @default.
• W4293766356 countsByYear W42937663562023 @default.
• W4293766356 crossrefType "journal-article" @default.
• W4293766356 hasAuthorship W4293766356A5012816071 @default.
• W4293766356 hasAuthorship W4293766356A5024700132 @default.
• W4293766356 hasAuthorship W4293766356A5030921116 @default.
• W4293766356 hasAuthorship W4293766356A5033516838 @default.
• W4293766356 hasAuthorship W4293766356A5035472496 @default.
• W4293766356 hasAuthorship W4293766356A5041837471 @default.
• W4293766356 hasAuthorship W4293766356A5049218383 @default.
• W4293766356 hasAuthorship W4293766356A5058901425 @default.
• W4293766356 hasAuthorship W4293766356A5063464747 @default.
• W4293766356 hasAuthorship W4293766356A5068851817 @default.
• W4293766356 hasAuthorship W4293766356A5077989094 @default.
• W4293766356 hasBestOaLocation W42937663561 @default.
• W4293766356 hasConcept C118552586 @default.
• W4293766356 hasConcept C126322002 @default.
• W4293766356 hasConcept C139719470 @default.
• W4293766356 hasConcept C159110408 @default.
• W4293766356 hasConcept C162324750 @default.
• W4293766356 hasConcept C169900460 @default.
• W4293766356 hasConcept C197934379 @default.
• W4293766356 hasConcept C2776867660 @default.
• W4293766356 hasConcept C2778034309 @default.
• W4293766356 hasConcept C2778375690 @default.
• W4293766356 hasConcept C2779177272 @default.
• W4293766356 hasConcept C2779951463 @default.
• W4293766356 hasConcept C2780051608 @default.
• W4293766356 hasConcept C558461103 @default.
• W4293766356 hasConcept C71924100 @default.
• W4293766356 hasConceptScore W4293766356C118552586 @default.
• W4293766356 hasConceptScore W4293766356C126322002 @default.
• W4293766356 hasConceptScore W4293766356C139719470 @default.
• W4293766356 hasConceptScore W4293766356C159110408 @default.
• W4293766356 hasConceptScore W4293766356C162324750 @default.
• W4293766356 hasConceptScore W4293766356C169900460 @default.
• W4293766356 hasConceptScore W4293766356C197934379 @default.
• W4293766356 hasConceptScore W4293766356C2776867660 @default.
• W4293766356 hasConceptScore W4293766356C2778034309 @default.
• W4293766356 hasConceptScore W4293766356C2778375690 @default.
• W4293766356 hasConceptScore W4293766356C2779177272 @default.
• W4293766356 hasConceptScore W4293766356C2779951463 @default.
• W4293766356 hasConceptScore W4293766356C2780051608 @default.
• W4293766356 hasConceptScore W4293766356C558461103 @default.

• next